SHALBY Stock Overview
Shalby Limited operates multi-specialty hospitals primarily in India, North America, Japan, and Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Shalby Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹266.65 |
| 52 Week High | ₹339.50 |
| 52 Week Low | ₹135.00 |
| Beta | 1.04 |
| 1 Month Change | 13.95% |
| 3 Month Change | -15.62% |
| 1 Year Change | 81.95% |
| 3 Year Change | 131.57% |
| 5 Year Change | 104.09% |
| Change since IPO | 11.29% |
Recent News & Updates
Recent updates
Market Cool On Shalby Limited's (NSE:SHALBY) Earnings Pushing Shares 26% Lower
Mar 14
These 4 Measures Indicate That Shalby (NSE:SHALBY) Is Using Debt Reasonably Well
Nov 22Is Now The Time To Look At Buying Shalby Limited (NSE:SHALBY)?
Nov 01We Like These Underlying Return On Capital Trends At Shalby (NSE:SHALBY)
Sep 06Returns On Capital At Shalby (NSE:SHALBY) Have Stalled
Jan 01Shalby (NSE:SHALBY) Is Due To Pay A Dividend Of ₹1.00
Sep 11Shalby (NSE:SHALBY) Is Due To Pay A Dividend Of ₹1.00
Aug 28Shalby (NSE:SHALBY) Will Be Hoping To Turn Its Returns On Capital Around
Aug 19Is Shalby (NSE:SHALBY) Using Too Much Debt?
Jun 21Returns On Capital At Shalby (NSE:SHALBY) Paint A Concerning Picture
Apr 06Here's Why We Think Shalby (NSE:SHALBY) Is Well Worth Watching
Feb 25Why Shalby Limited (NSE:SHALBY) Could Be Worth Watching
Jun 30Shalby (NSE:SHALBY) Will Will Want To Turn Around Its Return Trends
May 12Shalby (NSE:SHALBY) Has A Pretty Healthy Balance Sheet
Mar 30Is Now The Time To Look At Buying Shalby Limited (NSE:SHALBY)?
Mar 16What Kind Of Shareholders Hold The Majority In Shalby Limited's (NSE:SHALBY) Shares?
Mar 03What Type Of Returns Would Shalby's(NSE:SHALBY) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Feb 19Should You Buy Shalby Limited (NSE:SHALBY) For Its Dividend?
Feb 08We're Watching These Trends At Shalby (NSE:SHALBY)
Jan 26Shalby Limited's (NSE:SHALBY) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 14Did Shalby Limited (NSE:SHALBY) Insiders Buy Up More Shares?
Dec 30
Is Shalby (NSE:SHALBY) Using Too Much Debt?
Dec 15What Type Of Shareholders Make Up Shalby Limited's (NSE:SHALBY) Share Registry?
Nov 30Would Shareholders Who Purchased Shalby's (NSE:SHALBY) Stock Year Be Happy With The Share price Today?
Nov 12Key Things To Watch Out For If You Are After Shalby Limited's (NSE:SHALBY) 0.5% Dividend
Oct 28Will Shalby (NSE:SHALBY) Multiply In Value Going Forward?
Oct 12Shareholder Returns
| SHALBY | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -3.9% | -4.1% | -2.5% |
| 1Y | 82.0% | 61.1% | 44.5% |
Return vs Industry: SHALBY exceeded the Indian Healthcare industry which returned 61.1% over the past year.
Return vs Market: SHALBY exceeded the Indian Market which returned 44.5% over the past year.
Price Volatility
| SHALBY volatility | |
|---|---|
| SHALBY Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: SHALBY has not had significant price volatility in the past 3 months.
Volatility Over Time: SHALBY's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 2,678 | Vikram Shah | www.shalby.org |
Shalby Limited operates multi-specialty hospitals primarily in India, North America, Japan, and Indonesia. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implantology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver transplant, dermatology, psychiatry, urology, anesthesia, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neurosurgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, spine surgery, and urosurgery services, as well as organ donation.
Shalby Limited Fundamentals Summary
| SHALBY fundamental statistics | |
|---|---|
| Market cap | ₹28.73b |
| Earnings (TTM) | ₹813.76m |
| Revenue (TTM) | ₹8.89b |
35.2x
P/E Ratio3.2x
P/S RatioIs SHALBY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHALBY income statement (TTM) | |
|---|---|
| Revenue | ₹8.89b |
| Cost of Revenue | ₹6.55b |
| Gross Profit | ₹2.33b |
| Other Expenses | ₹1.52b |
| Earnings | ₹813.76m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.58 |
| Gross Margin | 26.24% |
| Net Profit Margin | 9.16% |
| Debt/Equity Ratio | 16.7% |
How did SHALBY perform over the long term?
See historical performance and comparison